We are live on ! Find out more

1,762 hedge funds and large institutions have $119B invested in Merck in 2016 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 713 increasing their positions, 710 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 59

30% more funds holding in top 10

Funds holding in top 10: 106138 (+32)

11% more capital invested

Capital invested by funds: $107B → $119B (+$11.6B)

1% more funds holding

Funds holding: 1,7451,762 (+17)

0% more repeat investments, than reductions

Existing positions increased: 713 | Existing positions reduced: 710

0.6% less ownership

Funds ownership: 78.67%78.07% (-0.6%)

14% less call options, than puts

Call options by funds: $1.02B | Put options by funds: $1.18B

Holders
1,762
Holders Change
+17
Holders Change %
+0.97%
% of All Funds
47%
Holding in Top 10
138
Holding in Top 10 Change
+32
Holding in Top 10 Change %
+30.19%
% of All Funds
3.68%
New
92
Increased
713
Reduced
710
Closed
59
Calls
$1.02B
Puts
$1.18B
Net Calls
-$163M
Net Calls Change
-$87M
Name Holding Trade Value Shares
Change
Change in
Stake
MSS
1051
Mitchell Sinkler & Starr
Pennsylvania
$1.52M -$33.5K -629 -2%
HL
1052
HeadInvest LLC
Maine
$1.51M +$11.2K +210 +0.8%
GVT
1053
Genesee Valley Trust
New York
$1.51M +$37.4K +702 +3%
PIM
1054
Penobscot Investment Management
Massachusetts
$1.51M -$16.7K -314 -1%
PG
1055
Patten Group
Tennessee
$1.51M -$2.5K -47 -0.2%
CPA
1056
Court Place Advisors
Maryland
$1.5M +$16.8K +316 +1%
VFA
1057
Voya Financial Advisors
Connecticut
$1.49M -$25.5K -479 -2%
CFA
1058
Camarda Financial Advisors
Florida
$1.48M +$35K +657 +2%
AC
1059
AFAM Capital
Texas
$1.48M -$11.7K -219 -0.8%
FC
1060
FIC Capital
New York
$1.47M -$152K -2,861 -10%
CS
1061
Cannell & Spears
New York
$1.46M -$11.2K -210 -0.8%
CPA
1062
Capital Planning Advisors
California
$1.45M
GWI
1063
Grace & White Inc
New York
$1.45M -$390K -7,336 -22%
BJL
1064
Brighton Jones LLC
Washington
$1.45M -$31.3K -588 -2%
NIM
1065
Northeast Investment Management
Massachusetts
$1.45M +$16.1K +303 +1%
MCM
1066
Maple Capital Management
Vermont
$1.45M -$17.5K -329 -1%
EGA
1067
E&G Advisors
Texas
$1.43M -$150K -2,825 -10%
BHBT
1068
Burke & Herbert Bank & Trust
Virginia
$1.43M -$58.4K -1,097 -4%
WRM
1069
Westport Resources Management
Connecticut
$1.41M -$23.2K -436 -2%
GJIC
1070
Gamble Jones Investment Counsel
California
$1.41M +$85K +1,597 +7%
RMDI
1071
R.M. Davis Inc
Maine
$1.41M +$172K +3,226 +14%
KCM
1072
Kanawha Capital Management
Virginia
$1.41M -$3.19K -60 -0.2%
IAMOG
1073
Investors Asset Management of Georgia
Georgia
$1.41M +$5.59K +105 +0.4%
WFG
1074
Wills Financial Group
Virginia
$1.41M +$10.5K +198 +0.8%
PGA
1075
Portland Global Advisors
Maine
$1.4M -$85.1K -1,599 -6%

MRK Hedge Fund Activity: Q2 2016 in Review

1,762 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2016, worth a combined $119B — up 11% from $107B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new MRK positions and 59 closed out — a net gain of 33 holders — while 713 added to existing stakes and 710 trimmed.

The largest buyer was Macquarie Group, adding an estimated $718M. The largest seller was Royal London Asset Management, cutting an estimated $1.98B.

  • 1,762 institutional investors held Merck (MRK) as of Q2 2016, up from 1,745 in Q1 2016.
  • Funds reported $119B of Merck stock for Q2 2016, up 11% quarter-over-quarter.
  • 92 funds opened new Merck positions in Q2 2016 and 59 closed out, a net change of +33 holders.
  • The largest Merck buyer in Q2 2016 was Macquarie Group, an estimated $718M added.
  • The largest Merck seller in Q2 2016 was Royal London Asset Management, an estimated $1.98B sold.

Based on aggregated 13F filings for Q2 2016.